NewLink Genetics to Participate in Upcoming Investor Conferences

AMES, Iowa, April 30, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK) announced today that the company will participate in the following investor conferences:

• Deutsche Bank 43rd Annual Health Care Conference on May 9 at 11:20 AM ET in Boston 
• Bank of America Merrill Lynch Global Healthcare Conference 2018 on May 16 at 5:15 PM PT (8:15PM ET) in Las Vegas

A live webcast of both conference presentations will be available on the Company’s website at www.newlinkgenetics.com in the “Investors & Media” section under “Events and Presentations.”

About NewLink Genetics CorporationNewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' IDO pathway inhibitors are designed to harness multiple components of the immune system to combat cancer. For more information, please visit www.newlinkgenetics.com and follow us on Twitter @NLNKGenetics.

Investor Contact:

Lisa MillerDirector of Investor RelationsNewLink Genetics515-598-2555[email protected]

Media Contact:

Sharon CorreiaVP, Integrated CommunicationsLaVoieHealthScience617-374-8800, ext. 105[email protected]

Source: NewLink Genetics Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• VICI Properties closes $1.75B senior unsecured notes offering
• SaunaCloud Founder Christopher Kiggins Explains Why Informed Customers Make Better Buyers in New Fast Company Article
• Best Crypto Portfolio: Genesis Wallet Wakes After 11 Years While Pepeto Races Toward Listing Day